Filing Flows › Comparisons › ACAD vs PBH
Acadia Pharmaceuticals vs Prestige Consumer Healthcare: ACAD and PBH compared
Acadia Pharmaceuticals is the larger company: $342M of revenue in its latest quarter (Q3 2026) against $336M for Prestige Consumer Healthcare (Q2 FY27). Acadia Pharmaceuticals is growing faster (+23% against +23% a year earlier). Prestige Consumer Healthcare is more profitable, with an operating margin of 24.0% against 21.0%.
Where the money goes: ACAD and PBH
Acadia Pharmaceuticals (ACAD) · Q3 2026
Acadia Pharmaceuticals, Q3 2026: revenue $342M (+23% year over year), operating margin 21.0%, net earnings $53.5M, operating cash flow $11.5M. The chart follows the revenue to costs, profit and cash.
Prestige Consumer Healthcare (PBH) · Q2 FY27
Prestige Consumer Healthcare, Q2 FY27: revenue $336M (+23% year over year), operating margin 24.0%, net earnings $25.3M, operating cash flow $37.9M. The chart follows the revenue to costs, profit and cash.
| Acadia Pharmaceuticals (ACAD) | Prestige Consumer Healthcare (PBH) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 FY27 |
| Revenue | $342M | $336M |
| Revenue growth, Y/Y | +23% | +23% |
| Gross margin | — | 51.3% |
| Operating margin | 21.0% | 24.0% |
| Net earnings | $53.5M | $25.3M |
| Net margin | 15.6% | 7.5% |
| Operating cash flow | $11.5M | $37.9M |
| Free cash flow | $10.3M | $34.2M |
| Market value | $3.7B | $2.3B |
| P/E | 10.3× | 13.6× |
| Analysts’ mean target | $30.68 | $66.60 |
Where the revenue comes from
Acadia Pharmaceuticals
- Nuplazid: $202M (59%)
- Daybue: $140M (41%)
Prestige Consumer Healthcare
- Gastrointestinal: $63.1M (19%)
- Women's Health: $53.6M (16%)
- Wellness, Sleep & Other: $47.3M (14%)
- Dermatologicals: $43.9M (13%)
Questions
Which is bigger, Acadia Pharmaceuticals or Prestige Consumer Healthcare?
Acadia Pharmaceuticals is the larger company: $342M of revenue in its latest quarter (Q3 2026) against $336M for Prestige Consumer Healthcare (Q2 FY27).
Is Acadia Pharmaceuticals or Prestige Consumer Healthcare growing faster?
Acadia Pharmaceuticals is growing faster (+23% against +23% a year earlier).
Which is more profitable, Acadia Pharmaceuticals or Prestige Consumer Healthcare?
Prestige Consumer Healthcare is more profitable, with an operating margin of 24.0% against 21.0%.
More: Acadia Pharmaceuticals earnings · how Acadia Pharmaceuticals makes money · Prestige Consumer Healthcare earnings · how Prestige Consumer Healthcare makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.